AI in Drug Discovery Market by Drug Type (Small Molecule and Large Molecule) by Technology (Deep Learning, Machine Learning and Others) by Application (Target Identification and Validation, Drugs Design and Redesign, Preclinical Testing and Others), by Organization Size (Small and Medium Organizations and Large Organizations) by Therapeutic Area (Cardiovascular Disease, Metabolic Disease, Neurodegenerative Diseases, Dermatological Diseases, Infectious Diseases, Oncology and Others) by End Users (Pharmaceutical Companies, Research Centers and Laboratories, Clinicians and Drug Developers and Others); By Region (U.S., Canada, Mexico, Rest of North America, France, UK, Germany, Spain, Italy, Nordic Countries, Benelux Union, Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Rest of Asia Pacific, Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of MEA, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2020 - 2028

Report ID :AMI-731 | Category : Healthcare & IT | Published Date : June, 3300 | Pages : 402 | Format :PDF